Skip to content

Drug interactions

Remifentanil + Selegiline transdermal

Severity: Major

Remifentanil and Selegiline transdermal: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Selegiline is an MAO inhibitor, and combining MAOIs with opioids can precipitate serotonin syndrome or other severe reactions. The risk is higher with serotonergic opioids, and remifentanil is less serotonergic, but caution is still warranted.

What this interaction means in plain words

Remifentanil and Selegiline transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

MAO inhibition combined with opioid effects may increase serotonergic and sympathetic activity.

What to do

Avoid use where possible, or use only with close monitoring for agitation, hyperthermia, rigidity and blood pressure changes. Choose non-serotonergic analgesic alternatives and stop both agents if serotonin syndrome develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Remifentanil and Selegiline transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Remifentanil with Selegiline transdermal?

MediHelp rates the interaction as major. Remifentanil and Selegiline transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Selegiline is an MAO inhibitor, and combining MAOIs with opioids can precipitate serotonin syndrome or other severe reactions. The risk is higher with serotonergic opioids, and remifentanil is less serotonergic, but caution is still warranted.

How serious is the interaction between Remifentanil and Selegiline transdermal?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid use where possible, or use only with close monitoring for agitation, hyperthermia, rigidity and blood pressure changes. Choose non-serotonergic analgesic alternatives and stop both agents if serotonin syndrome develops.

What other medicines interact with Remifentanil?

MediHelp also lists interactions of Remifentanil with, for example, Alvimopan, Isocarboxazid, Olanzapine / samidorphan. The full list is on the Remifentanil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in